CTSHCognizant

$59.19-14% 1Y

The financials

Cognizant by the numbers

Cognizant (CTSH) reported revenue of $5.41B in Q1 2026 (quarter ended Mar 31, 2026), up 5.8% from the same quarter a year earlier. That came with a gross margin of 33% and net income of $662M (12% of revenue). For the full year FY2025, revenue was $21.1B (+7.0% year on year) and net income $2.23B. Its largest segment in Jun 2026 was Health Sciences at $1.31B, 32% of the disclosed total, just ahead of Financial Services at 31%. The next results filing is expected around Oct 28, 2026, the same week as a year ago.

Cognizant income statement, Q1 2026 against the same quarter a year earlier
Income statementQ1 2026Q1 2025Change
Revenue$5.41B$5.12B+5.8%
Gross profit$1.77B$1.72B+3.3%
Operating income$843M$853M−1.2%
Net income$662M$663M−0.2%
Diluted EPS$1.39$1.34+3.7%
Revenue by segment, Jun 2026, as reported to the SEC
OperatingRevenueShare
Health Sciences$1.31B32%
Financial Services$1.26B31%
Productsand Resources$918M22%
Communications Media And Technology$639M15%

Business segments

Revenue split by operating segment, from SEC XBRL filings.

Latest period: Jun 2026Total $4.13B (+1.9%)
Financial Services grew +15% year on yearProducts and Resources 0.00% year on year
  • Health Sciences$1.31Bquarter on quarter -0.31%year on year +0.69%
  • Financial Services$1.26Bquarter on quarter +7.4%year on year +15%
  • Products and Resources$918.0Mquarter on quarter +0.22%year on year 0.00%
  • Communications Media And Technology$639.0Mquarter on quarter -1.5%year on year +6.5%
Segment sum = 75% of reported consolidated revenue (partial disaggregation) · Latest source: 10-Q filed Jul 29, 2026, SEC EDGAR